Immunogenicity of a Live Dengue Vaccine (TAK-003)

被引：4
|
作者：
de Silva, Aravinda [1 ]
White, Laura [1 ]
机构：
[1] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 2022年 / 227卷 / 01期
关键词：
D O I：
10.1093/infdis/jiac424
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：163 / 164
页数：2
相关论文
共 50 条
  • [31] Safety signal detected: Anaphylaxis after attenuated dengue vaccine (TAK-003) - Brazil, march 1, 2023-march 11, 2024
    Percio, Jadher
    Kobayashi, Carla Dinamerica
    Silva, Roberta Mendes Abreu
    Marinho, Ana Karolina Barreto Berselli
    Capovilla, Leon
    Andrade, Paulo Henrique Santos
    da Nobrega, Martha Elizabeth Brasil
    Cabral, Cibelle Mendes
    de Moraes, Monica Brauner
    Werneck, Guilherme Loureiro
    Fernandes, Eder Gatti
    VACCINE, 2024, 42 (26)
  • [32] A Methodological Approach to Measuring the Impact of TAK-003 for the Prevention of Dengue in Dourados, Brazil: Optimizing Strategies for Public Health
    Ghezzi, Benedetta
    Valencia, Cristina
    de Oliveira, Roberto Dias
    Tsuha, Daniel
    Lucena Junior, Waldno
    Di Pasquale, Alberta
    Mc Namara, Morgan
    Senra, Juliana
    Abud, Denise
    Croda, Julio
    VACCINES, 2025, 13 (02)
  • [33] IgG, IgM, and Nonstructural Protein 1 Response Profiles after Receipt of Tetravalent Dengue Vaccine TAK-003 in a Phase 2 Randomized Controlled Trial
    Low, Jenny G.
    Oh, Helen M.
    Leo, Yee-Sin
    Kalimuddin, Shirin
    Wijaya, Limin
    Pang, Junxiong
    Lee, Tau Hong
    Moss, Kelley J.
    Brose, Manja
    Tricou, Vianney
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2024, 111 (01): : 102 - 106
  • [34] EFFICACY AND SAFETY OF TAKEDA'S TETRAVALENT DENGUE VACCINE CANDIDATE (TAK-003) AFTER 4.5 YEARS OF FOLLOW-UP: RESULTS FROM PARTICIPANTS IN ASIA
    Green, A.
    Biswal, S.
    Lloyd, E.
    Tricou, V.
    Folschweiller, N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S11 - S11
  • [35] ASSESSING THE VALUE OF DENGUE VACCINE TAK 003: A COST-EFFECTIVENESS STUDY IN MALAYSIA
    Azzeri, A.
    Jaafar, H.
    Ting, R.
    Langer, J.
    Dahlui, M.
    VALUE IN HEALTH, 2024, 27 (12) : S110 - S111
  • [36] DISEASE IMPACT AND COST-EFFECTIVENESS OF A NEW DENGUE VACCINE TAK003 IN THAILAND
    Shen, J.
    Kharitonova, E.
    Biswal, S.
    Sharma, M.
    Aballea, S.
    Tytula, A.
    Zawieja, J.
    Towle, P.
    Hanley, R.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S141 - S141
  • [37] Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4.5-year results from a phase 3, randomised, double-blind, placebo-controlled trial
    Tricou, Vianney
    Yu, Delia
    Reynales, Humberto
    Biswal, Shibadas
    Saez-Llorens, Xavier
    Sirivichayakul, Chukiat
    Lopez, Pio
    Borja-Tabora, Charissa
    Bravo, Lulu
    Kosalaraksa, Pope
    Vargas, Luis Martinez
    Alera, Maria Theresa
    Rivera, Luis
    Watanaveeradej, Veerachai
    Dietze, Reynaldo
    Fernando, Lakkumar
    Wickramasinghe, V. Pujitha
    Moreira Jr, Edson Duarte
    Fernando, Asvini D.
    Gunasekera, Dulanie
    Luz, Kleber
    Oliveira, Ana Lucia
    Tuboi, Suely
    Escudero, Ian
    Hutagalung, Yanee
    Lloyd, Eric
    Rauscher, Martina
    Zent, Olaf
    Folschweiller, Nicolas
    LeFevre, Inge
    Espinoza, Felix
    Wallace, Derek
    LANCET GLOBAL HEALTH, 2024, 12 (02): : E257 - E270
  • [38] The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
    Kirkpatrick, Beth D.
    Whitehead, Stephen S.
    Pierce, Kristen K.
    Tibery, Cecilia M.
    Grier, Palmtama L.
    Hynes, Noreen A.
    Larsson, Catherine J.
    Sabundayo, Beulah P.
    Talaat, Kawsar R.
    Janiak, Anna
    Carmolli, Marya P.
    Luke, Catherine J.
    Diehl, Sean A.
    Durbin, Anna P.
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (330)
  • [39] Impact of TAK-003 on epidemiologic, economic and quality-of-life burden of dengue: comparison of the results from a dynamic transmission model and a static model with a dynamic component
    Kharitonova, Elizaveta
    Shen, Jing
    Tytula, Anna
    Zawieja, Justyna
    Rojas, Yaneth Gil
    Aballea, Samuel
    Hanley, Riona
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2025, 152
  • [40] Exanthema after dengue vaccine (TAK003): first data of passive surveillance in a private vaccination center in Argentina
    Castellano, Vanesa E.
    Orduna, Tomas
    Burgos, Fernando
    Leiro, Viviana
    Sosa, Nadia
    Bonvehi, Pablo
    MEDICINA-BUENOS AIRES, 2024, 84 (05) : 852 - 859
12345